| Product Code: ETC8559247 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Encephalitis Vaccine Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Encephalitis Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Encephalitis Vaccine Market - Industry Life Cycle |
3.4 New Zealand Encephalitis Vaccine Market - Porter's Five Forces |
3.5 New Zealand Encephalitis Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 New Zealand Encephalitis Vaccine Market Revenues & Volume Share, By Strain, 2021 & 2031F |
3.7 New Zealand Encephalitis Vaccine Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 New Zealand Encephalitis Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about encephalitis and its prevention measures |
4.2.2 Growing government initiatives to promote vaccination programs |
4.2.3 Rise in travel-related infections leading to higher demand for encephalitis vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and production |
4.3.2 Limited availability of healthcare infrastructure in remote areas |
4.3.3 Regulatory challenges and approval processes for new vaccines |
5 New Zealand Encephalitis Vaccine Market Trends |
6 New Zealand Encephalitis Vaccine Market, By Types |
6.1 New Zealand Encephalitis Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Mouse Brain-Derived, Inactivated Vaccine, 2021- 2031F |
6.1.4 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Cell Culture-Derived, Inactivated Vaccine, 2021- 2031F |
6.1.5 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Cell Culture-Derived, Live Attenuated Vaccine, 2021- 2031F |
6.2 New Zealand Encephalitis Vaccine Market, By Strain |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Nakayama, 2021- 2031F |
6.2.3 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Beijing, 2021- 2031F |
6.2.4 New Zealand Encephalitis Vaccine Market Revenues & Volume, By P-3, 2021- 2031F |
6.2.5 New Zealand Encephalitis Vaccine Market Revenues & Volume, By SA14-14-2, 2021- 2031F |
6.3 New Zealand Encephalitis Vaccine Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Child, 2021- 2031F |
6.3.3 New Zealand Encephalitis Vaccine Market Revenues & Volume, By Adult, 2021- 2031F |
7 New Zealand Encephalitis Vaccine Market Import-Export Trade Statistics |
7.1 New Zealand Encephalitis Vaccine Market Export to Major Countries |
7.2 New Zealand Encephalitis Vaccine Market Imports from Major Countries |
8 New Zealand Encephalitis Vaccine Market Key Performance Indicators |
8.1 Number of public health campaigns promoting encephalitis vaccination |
8.2 Percentage increase in government funding for vaccination programs |
8.3 Number of reported encephalitis cases in New Zealand |
8.4 Rate of vaccine coverage among high-risk populations |
8.5 Number of clinical trials and research studies on encephalitis vaccines conducted in New Zealand |
9 New Zealand Encephalitis Vaccine Market - Opportunity Assessment |
9.1 New Zealand Encephalitis Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 New Zealand Encephalitis Vaccine Market Opportunity Assessment, By Strain, 2021 & 2031F |
9.3 New Zealand Encephalitis Vaccine Market Opportunity Assessment, By End user, 2021 & 2031F |
10 New Zealand Encephalitis Vaccine Market - Competitive Landscape |
10.1 New Zealand Encephalitis Vaccine Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Encephalitis Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |